New ACACIA-HCM analyses at HCMS 2026 add imaging and quality-of-life data as Cytokinetics readies an FDA filing in nonobstructive HCM.
An oral SERD plus everolimus cut the risk of progression or death by 62% in ESR1-mutated advanced breast cancer.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Cardiologists and pharmacy leaders explained how team-based clinics and standardized paperwork are speeding obstructive HCM ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Prerna Mewawalla, MD, discusses fixed-duration bispecifics to limit infection risk and real-world data showing poor outcomes ...
FDA grants accelerated approval to neladalkib for previously treated locally advanced or metastatic ALK-positive non-small ...
New York hepatitis B experts say screening gaps and weekly monitoring demands could limit who benefits from the first functional cure therapy.
Nearly 90% of patients in the MINT trial tapered prednisone to 5 mg/day or less, with no significant safety concerns seen to ...
Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics.
IL-23 inhibitors linked to lower psoriatic arthritis risk than JAK inhibitors, and IL-17 inhibitors showed higher risk.